Recent Securities Litigations

Emergent Biosolutions Inc. Common Stock (NYSE: EBS)

Company Name:Emergent Biosolutions Inc. Common Stock
Stock Symbol:NYSE: EBS
Class Period Start:04/24/2020
Class Period End (inclusive):04/16/2021

The Complaint alleges that the Company failed to disclose to investors myriad issues at Bayview that would detrimentally affect its ability to manufacture the vaccine. The Complaint further alleges that as a result of Defendants’ wrongful acts and omissions, and the precipitous decline in the market value of the Company’s common stock, Plaintiff and the other Class members have suffered significant losses and damages.